Blueprint Medicines Corporation (BPMC) financial statements (2020 and earlier)

Company profile

Business Address 45 SIDNEY STREET
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:548494673268163
Cash and cash equivalents1146840052163
Short-term investments370426273162 
Other undisclosed cash, cash equivalents, and short-term investments64(0)054 
Restricted cash and investments 0  0
Receivables1    
Other undisclosed current assets(32)612(48)8
Total current assets:517500686220170
Noncurrent Assets
Operating lease, right-of-use asset73
Property, plant and equipment38302467
Long-term investments and receivables64  54 
Long-term investments64  54 
Restricted cash and investments55511
Other noncurrent assets106111
Total noncurrent assets:1914030628
TOTAL ASSETS:708540716283179
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities935534149
Accounts payable53422
Accrued liabilities895231126
Deferred revenue6
Debt7 233
Deferred compensation liability    0
Deferred revenue and credits5116
Contract with customer, liability4
Other undisclosed current liabilities 2211
Total current liabilities:10660432919
Noncurrent Liabilities
Long-term debt and lease obligation89  24
Long-term debt, excluding current maturities   24
Operating lease, liability89
Liabilities, other than long-term debt484834379
Deferred revenue and credits34379
Deferred revenue40
Contract with customer, liability43
Deferred compensation liability, classified    0
Deferred rent credit 5
Other liabilities80000
Other undisclosed noncurrent liabilities 13   
Total noncurrent liabilities:13761343813
Total liabilities:243121776732
Stockholders' equity
Stockholders' equity attributable to parent464419624213144
Common stock00000
Additional paid in capital1,4121,017980421279
Accumulated other comprehensive loss(3)(0)(0)(0) 
Accumulated deficit(945)(598)(356)(207)(135)
Total stockholders' equity:464419624213144
Other undisclosed liabilities and equity  1533
TOTAL LIABILITIES AND EQUITY:708540716283179

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Gross profit:6745212811
Operating expenses(428)(292)(173)(100)(63)
Operating loss:(361)(247)(151)(73)(52)
Nonoperating income (expense)141030(1)
Other nonoperating income (expense)(0)1031(0)
Interest and debt expense (0)(0)(0)(1)
Loss before gain (loss) on sale of properties:(348)(237)(148)(73)(53)
Other undisclosed net income 00  
Net loss:(348)(237)(148)(73)(53)
Other undisclosed net income attributable to parent   01
Net loss attributable to parent:(348)(237)(148)(72)(53)
Preferred stock dividends and other adjustments    (3)
Net loss available to common stockholders, diluted:(348)(237)(148)(72)(56)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(348)(237)(148)(73)(53)
Other comprehensive income10   
Comprehensive loss:(347)(237)(148)(73)(53)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(3)(0)(0)0 
Comprehensive loss, net of tax, attributable to parent:(350)(237)(148)(73)(53)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: